Sentence examples for mean plaque density from inspiring English sources

By ultrasound assessment of the bifurcations of carotid and femoral arteries, maximum combined plaque/intima-media thickness (CPIMTmax) and mean plaque density (MPD, in a grey scale from 0 to 255) were also measured.

The number of PrP plaques was manually counted, and the mean plaque density in each brain region was calculated.

As expected, mean plaque density was significantly higher at 18 months of age (191 mm-3; 126–292 mm-3 CI) compared to 12 and 14 months of age.

Long-term imaging revealed no further significant increase in mean plaque density, which peaked at a plateau of 160 mm-3 (100–255 mm-3 CI) at 24 months of age.

Mean plaque density started very low in the young cohort at 26.2 mm-3 (13.8-49.8 mm-3 CI), but increased to 42.0 mm-3 (23.2-75.7 mm-3 CI) during the 2-month observation period.

Patients with AD had a mean clinical dementia rating of 3.3, a Braak Stage score average of 5.7 (see [ 44] for staging classification), a mean cortical plaque density of 19.8 based on measurements from five cortical brain regions [ 44], and a mean AOD of 79.1 years (range, 66 92 years).

These individuals had a neuritic plaque density average of 2 (SD = 1.2; 0 = none; 1 = sparse; 2 = moderate; and 3 = frequent) and a Braak stage mean of 4.2 (SD = 1.6) at death.

The correlation average of A β plaque density, burden area, and antibody titers were analyzed and compared in multiple groups by one-way analysis of variance (ANOVA), followed by Fisher's LSD post hoc means comparison test analysis when relevant.

The cutoff value was derived from the F-flutemetamol phase 3 study using a binarized measure of postmortem brain neuritic plaque density [ 16] (overall mean Bielschowsky score below or above 1.5 [ 15]).

Controls were determined to have negligible cortical plaque densities (mean, 0.64), and either no evidence of or only mild clinical symptoms of dementia (mean clinical dementia rating, 0.87; mean Braak Stage score, 1.4), with a mean AOD of 80.5 years (range, 66 95 years).

The first parameter that was evaluated was the mean plaque score: All three groups had a reduction in plaque scores that continued throughout the 12-month period.